Why do scars turn purple

Overview

Scar coloration has been observed and documented since ancient medical practices, with Hippocrates noting wound healing patterns around 400 BCE. Modern understanding of scar pigmentation emerged in the 20th century with advances in dermatology and wound healing research. The purple phase of scarring represents a specific stage in the body's complex repair process, occurring after initial scab formation but before final tissue remodeling. This transitional coloration affects millions annually, with approximately 100 million people developing scars from surgical procedures alone each year worldwide. Historical treatments for scar discoloration included herbal poultices and early 20th-century radiation therapy, while contemporary approaches focus on minimizing inflammation and promoting proper healing from the initial injury onward.

How It Works

The purple appearance of scars develops through a specific biological sequence beginning with the inflammatory phase of wound healing. When skin is injured, blood vessels dilate to increase blood flow to the area, bringing immune cells and nutrients. This vascular response, combined with the breakdown of hemoglobin from red blood cells trapped in the tissue, creates a bluish-purple hue visible through the epidermis. The color intensity peaks around 2-3 weeks post-injury as angiogenesis (new blood vessel formation) reaches its maximum. During this period, fibroblasts produce type III collagen that appears more vascularized than mature scar tissue. As healing progresses into the remodeling phase (months 3-6), blood vessel density decreases by approximately 60%, collagen reorganizes into stronger type I fibers, and the purple coloration gradually fades through shades of pink to eventually become hypopigmented or white in many cases.

Why It Matters

Understanding why scars turn purple has significant implications for both medical treatment and psychological well-being. Medically, purple scarring serves as a visual indicator of healing progression, helping clinicians assess whether wounds are following normal recovery timelines or developing complications like hypertrophic or keloid scars. This knowledge informs treatment decisions, from timing interventions like silicone sheets (most effective when started as purple fades to pink) to selecting appropriate laser therapies for persistent discoloration. Psychologically, scar appearance affects approximately 30% of patients' quality of life according to dermatology studies, with purple scars often causing concern about healing abnormalities. Proper education about normal color progression can reduce patient anxiety and prevent unnecessary treatments. Additionally, this understanding drives development of better scar management products and techniques, potentially reducing the $12 billion annual cost of scar revision procedures in the United States alone.